Keywords
- Hepatocellular Carcinoma
- Liver Metastasis
- Colorectal Liver Metastasis
- Percutaneous Ethanol Injection
- Intrahepatic Cholangiocarcinoma
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, access via your institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Diagnostic
Bohm, B., Voth, M., Georghegan, J., Heltfritzsch, H., Petrovich, A., Scheele, J., Gottschild, D.: Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors. J. Canc. Res. Clin. Oncol. 2004; 130: 266–272
Cosgrove, D., Blomley, M.: Liver tumors: Evaluation with contrastenhanced ultrasound. Abdom. Imag. 2004; 29: 446–454
Delbeke, D., Martin, W.H., Sandler, M.P., Chapman, W.C., Wright, J.K., Pinson, C.W.: Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch. Surg. 1998; 133: 510–516
Edmondson, H.A., Steiner, P.E.: Primary carcinoma of the liver. A study of 100 cases among 48900 autopsies. Cancer 1954; 7: 462–503
Eggel, H.: Über das primäre Carcinom der Leber. Beitr. Pathol. Anat. Allg. Pathol. 1901; 30: 506–604
Harris, C.C., Hollstein, M.: Clinical implications of the p53 tumor suppressor gene. New Engl. J. Med. 1993; 321: 1318–1327
Hermanek, P., Wittekind, C.: Residual tumour (R) classification and prognosis. Semin. Surg. Oncol. 1994; 10: 12–20
Konno, K., Ishida, H., Hamashima, Y., Komatsuda, T., Sato, M., Furuya, T., Asanuma, Y., Masamune, O.: Color Doppler findings of tumor seeding after US-guided liver tumor biopsy. Abdom. Imag. 1999; 24: 401–403
Kuntz, E.: 30 years’ experience with 6000 laparoscopies (1955–1986). Fortschr. Med. 1987; 105: 521–524 · Current status of laparoscopy in hepatology. Med. Welt 1999; 50: 42–47
Kuszyk, B.S., Bluemke, D.A., Urban, B.A., Choti, M.A., Hruban, R.H., Sitzmann, J.V., Fishman, E.K.: Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors. Amer. J. Roentgenol. 1996; 166: 91–95
Lemke, A.J., Chopra, S.S., Hengst, S.A., Brinkmann, M.J., Steinmüller, T., Felix, R.: Characterization of hepatic tumors with contrastenhanced ultrasound and digital grey-scale analysis. Fortschr. Röntgenstr. 2004; 176: 1607–1616
Mani, H., van Thiel, D.H.: Mesenchymal tumors of the liver. Clin. Liver Dis. 2001; 5: 219–257
Steiner, P.E.: Cancer of the liver and cirrhosis in trans-Saharan Africa and the United States of America. Cancer 1960; 13: 1085–1166
Summerskill, W.H.J., Adson, M.A.: Gynecomastia as a sign of hepatoma. Amer. J. Dig. Dis. 1962; 74: 250–254
Hepatocellular carcinoma
Akanuma, M., Yoshida, H., Okamoto, M., Ogura, K., Maeda, S., Hata, Y., Sato, S., Shiina, S., Kawabe, T., Shiratori, Y., Omata, M.: Risk factors for esophageal variceal bleeding in patients with hepatocellular carcinoma. Hepato-Gastroenterol. 2002; 49: 1039–1044
Arai, H., Saitoh, S., Matsumoto, T., Makita, F., Mitsugi, S., Yuasa, K., Takagi, H., Mori, M.: Hypertension as a paraneoplastic syndrome in hepatocellular carcinoma. J. Gastroenterol. 1999; 34: 530–534
Arii, S., Tanaka, J., Yamazoe, Y., Minematsu, S., Morino, T., Fujita, K., Maetani, S., Tobe, T.: Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer 1992; 69: 913–919
Bartolozzi, C., Lencioni, R., Ricci, P., Paolicchi, A., Rossi, P., Passariello, R.: Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US. Radiology 1998; 209: 387–393
Benvegnu, L., Noventa, F., Bernardinello, E., Pontisso, P., Gatta, A., Alberti, A.: Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development. Gut 2001; 48: 110–115
Berber, E., Garland, A.M., Engle, K.L., Rogers, S.J., Siperstein, A.E.: Laparoscopic ultrasonography and biopsy of hepatic tumors in 310 patients. Amer. J. Surg. 2004; 187: 213–218
Bilchik, A.J., Wood, T.F., Allegra, D., Tsioulias, G.J., Chung, M., Rose, D.M., Ramming, K.P., Morton, D.L.: Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms — a proposed algorithm. Arch. Surg. 2000; 135: 657–664
Bismuth, H., Majno, P.E., Adam, R.: Liver transplantation for hepatocellular carcinoma. Semin. Liver Dis. 1999; 19: 311–322
Bizollon, T., Rode, A., Bancel, B., Gueripel, V., Ducerf, C., Baulieux, J., Trepo, C.: Diagnostic value and tolerance of lipiodol-computed tomography for the detection of small hepatocellular carcinoma: correlation with pathologic examination of explanted livers. J. Hepatol. 1998; 28: 491–496
Bosch, F.X., Ribes, J., Diaz, M., Cleries, R.: Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127(Suppl. 1): 5–16
Botelli, R., Tibballs, J., Hochhauser, D., Watkinson, A., Dick, R., Burroughs, A.K.: Ultrasound screening for hepatocellular carcinoma (HCC) in cirrhosis: the evidence for an established clinical practice. Clin. Radiol. 1998; 53: 713–716
Boucher, E., Corbinais, S., Rolland, Y., Bourguet, P., Guyader, D., Boudjema, K., Meunier, B., Raoul, J.L.: Adjuvant intra-arterial injection of iodine-131-labelled lipiodol after resection of hepatocellular carcinoma. Hepatology 2003; 38: 1237–1241
Britto, M.R.C., Thomas, L.A., Balaratnam, N., Griffiths, A.P., Duane, P.D.: Hepatocellular carcinoma arising in non-cirrhotic liver in genetic haemochromatosis. Scand. J. Gastroenterol. 2000; 35: 889–893
Burkill, G.J.C., Mannion, E.M., Healy, J.C.: Lymph node enhancement at MRI with MnDPDP in primary hepatic carcinoma. Clin. Radiol. 2001; 56: 67–71
Caldwell, S.H., Crespo, D.M., Kang, H.S., Al-Osaimi, A.M.S.: Obesity and hepatocellular carcinoma. Gastroenterology 2004; 127(Suppl. 1): 97–103
Camma, C., Schepis, F., Orlando, A., Albanese, M., Shalied, L., Trevisani, F., Andreone, P., Craxi, A., Cottone, M.: Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials. Radiology 2002; 224: 47–54
Caturelli, E., Bisceglia, M., Fusilli, S., Squillante, M.M., Castelvetere, M., Siena, D.A.: Cytological vs. microhistological diagnosis of hepatocellular carcinoma. Comparative accuracies in the same fine-needle biopsy specimen. Dig. Dis. Sci. 1996; 41: 2326–2331
Caturelli, E., Solmi, L., Anti, M., Fusilli, S., Roselli, P., Andriulli, A., Fornari, F., del Vecchio Blanco, C., de Sio, I.: Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: A multicentre study. Gut 2004; 53: 1356–1362
Chapoutot, C., Perney, P., Fabre, D., Taourel, P., Bruel, J.M., Larrey, D., Domergue, I., Ciurana, A.J., Blanc, F.: Needle-tract seeding after percutaneous ultrasound guided needle biopsy of hepatocellular carcinoma. A study of 150 patients. Gastroenterol. Clin. Biol. 1999; 23: 552–556
Choi, B.I., Lee, J.Y., Han, J.K., Lee, J.M., Kim, S.H.: Contrastenhanced sonography for hepatocellular carcinoma. Intervirology 2004; 47: 162–168
CLIP: The Cancer of the Liver Italian Program investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 1998; 28: 751–755
CLIP: The Cancer of the Liver Italian Program investigators. Prospective validation of the CLIP score: a new prognosis system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000; 31: 840–845
Colagrande, S., la Villa, G., Bartolucci, M., Lanini, F., Barletta, G., Villari, N.: Spiral computed tomography versus ultrasound in the follow-up of cirrhotic patients previously treated for hepatocellular carcinoma: A prospective study. J. Hepatol. 2003; 39: 93–98
Collier, J., Sherman, M.: Screening for hepatocellular carcinoma. Hepatology 1998; 27: 273–278
Conti, J.A., Kemeny, N.: Type Ia glycogenosis associated with hepatocellular carcinoma. Cancer 1992; 69: 1320–1322
Cottone, M., Turri, M., Parisi, P., Orlando, A., Fiorentino, G., Virdone, R., Fusco, G., Grasso, R., Simonetti, R.G., Pagliaro, L.: Screening for hepatocellular carcinoma in patients with child’s A cirrhosis: an 8-year prospective study by ultrasound and alpha fetoprotein. J. Hepatol. 1994; 21: 1029–1034
Curley, S.A., Bomalaski, J.S., Ensor, C.M., Holtsberg, F.W., Clark, M.A.: Regression of hepatocellular cancer in a patient treated with arginine deiminase (case report). Hepato-Gastroenterol. 2003; 50: 1214–1216
Curley, S.A., Izzo, F., Delrio, P., Ellis, L.M., Granchi, J., Vallone, P., Fiore, F., Pignata, S., Daniele, B., Cremon, F.: Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies — Results in 123 patients. Ann. Surg. 1999; 230: 1–8
Daly, J.M., Kemeny, N., Oderman, P., Botel, J.: Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity. Arch. Surg. 1984; 119: 936–941
Del Olmo, J.A., Serra, M.A., Rodriguez, F., Escudero, K., Gilabert, S., Rodrigo, J.M.: Incidence and risk factors for hepatocellular carcinoma in 96 patients with cirrhosis. J. Canc. Res. Clin. Oncol. 1998; 124: 560–564
Dick, E.A., Joarder, R., de Jode, M., Taylor-Robinson, S.D., Thomas, H.C., Foster, G.R., Gedroyc, W.M.W.: MR-guided laser thermal ablation of primary and secondary liver tumours. Clin. Radiol. 2003; 58: 112–120
Ding, H., Kudo, M., Onda, H., Suetomi, Y., Minami, Y., Maekawa, K.: Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma. Amer. J. Roentgenol. 2001; 176: 661–666
Dong, B.W., Liang, P., Yu, X.L., Su, L., Yu, D.J., Cheng, Z.G., Zhang, J.: Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. Amer. J. Roentgenol. 2003; 180: 1547–1555
El-Serag, H.B.: Hepatocellular carcinoma. An epidemiologic view. J. Clin. Gastroenterol. 2002; 35(Suppl. 2): 72–78
Enwonwu, C.O.: The role of dietary aflatoxin in the genesis of hepatocellular cancer in developing countries. Lancet 1984/II: 956–958
Eriksson, S.J., Carlson, J., Velez, R.: Risk of cirrhosis and primary liver cancer in alpha1-antitrypsin deficiency. New Engl. J. Med. 1986; 314: 736–779
Farinati, F., de Maria, N., Marafin, C., Herszenyi, L., del Prato, St., Rinaldi, M., Perini, L., Cardin, R., Naccarato, R.: Unresectable hepatocellular carcinoma in cirrhosis. Survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization. Dig. Dis. Sci. 1996; 41: 2332–2339
Feo, C.F., Marrosu, A., Scanu, A.M., Ginesu, G.C., Fancellu, A., Migaleddu, V., Porcu, A.: Spontaneous regression of hepatocellular carcinoma: report of a case. Eur. J. Gastroenterol. Hepatol. 2004; 16: 933–936
Fiel, M.I., Min, A., Gerber, M.A., Faire, B., Schwartz, M., Thung, S.N.: Hepatocellular carcinoma in long-term oral contraceptive use. Liver 1996; 16: 372–376
Francanzani, A.L., Taioli, E., Sampietro, M., Fatta, E., Bertelli, C., Fiorelli, G., Fargion, S.: Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease. J. Hepatol. 2001; 35: 498–503
Frank, I.L., Tharakan, J., Vasudev, K.S., Isaacs, P.E.T.: Malignant hepatic tumours associated with previous exposure to thorotrast: four cases. Eur. J. Gastroenterol. Hepatol. 1996; 8: 1121–1124
Gambarin-Gelwan, M., Wolf, D.C., Shapiro, R., Schwartz, M.E., Min, A.D.: Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Amer. J. Gastroenterol. 2000; 95: 1535–1538
Gelatti, U., Donato, F., Tagger, A., Fantoni, C., Portolani, N., Ribero, M.L., Martelli, C., Trevisi, P., Covolo, L., Simonati, C., Nardi, G.: Etiology of hepatocellular carcinoma influences clinical and pathologic features but not patient survival. Amer. J. Gastroenterol. 2003; 98: 907–914
Geschwind, J.F., Ko, Y.H., Torbenson, M.S., Magee, C., Pedersen, P.L.: Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer 2002; 62: 3909–3913
Giorgio, A., Tarantino, L., de Stefano, G., Scala, V., Liorre, G., Scarano, F., Perrotta, A., Farella, N., Aloisio, V., Mariniello, N., Coppola, C., Francica, G., Ferraioli, G.: Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma. Amer. J. Roentgenol. 2003; 181: 479–484
Grasso, A., Watkinson, A.F., Tibballs, J.M., Burroughs, A.K.: Radiofrequency ablation in the treatment of hepatocellular carcinoma — a clinical viewpoint. J. Hepatol. 2000; 33: 667–672
Gritzmann, N.: Small hepatocellular carcinomas in patients with liver cirrhosis: potential and limitations of contrast-enhanced power Doppler sonography. Eur. J. Gastroenterol. Hepatol. 2003; 15: 881–883
Halteren, van, H.K., Salemans, J.M.J.I., Peters, H., Vreugdenhil, G., Driesser, W.M.M.: Spontaneous regression of hepatocellular carcinoma. J. Hepatol. 1997; 27: 211–215
Hanazaki, K., Kajikawa, S., Shimozawa, N., Mihara, M., Shimada, K., Hiraguri, M., Koide, N., Adachi, W., Amano, J.: Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. Amer. J. Surg. 2000; 191: 381–388
Hasegawa, K., Uesugi, H., Kubota, K., Ugawa, Y., Murayama, S., Kobayashi, T., Hippo, Y., Gunji, T., Ohnishi, S., Mori, M., Makuuchi, M.: Polymyositis as a paraneoplastic manifestation of hepatocellular carcinoma. Hepato-Gastroenterol. 2000; 47: 1425–1427
Hassan, M.M., Hwang, L.Y., Hatten, C.J., Swaim, M., Li, D., Abbruzzese, J.L., Beastley, P., Patt, Y.Z.: Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002; 36: 1206–1213
Huo, T.I., Huang, Y.H., Wu, J.C., Lee, P.C., Chang, F.Y., Lee, S.D.: Persistent retention of acetic acid is associated with complete tumour necrosis in patients with hepatocellular carcinoma undergoing percutaneous acetic acid injection. Scand. J. Gastroenterol. 2004; 39: 168–173
Idilman, R., de Maria, N., Colantoni, A., van Thiel, D.H.: Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma. J. Viral Hepatitis 1998; 5: 285–299
Ido, K., Nakazawa, Y., Isoda, N., Kawamoto, C., Nagamine, N., Ono, K., Hozumi, M., Sato, Y., Kimura, K., Sugano, K.: The role of laparoscopic US and laparoscopic US-guided aspiration biopsy in the diagnosis of multicentric hepatocellular carcinoma. Gastrointest. Endosc. 1999; 50: 523–526
Iiai, T., Sato, Y., Nabatame, N., Yamamoto, S., Makino, S., Hatakeyama, K.: Spontaneous complete regression of hepatocellular carcinoma with portal vein tumor thrombus (case report). Hepato-Gastroenterol. 2003; 50: 1628–1630
Ikeda, K., Kumada, H., Saitoh, S., Arase, Y., Chayama, K.: Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. Cancer 1991; 68: 2150–2154
Imamura, M., Shiratori, Y., Shiina, S., Sato, S., Obi, S., Okudaira, T., Teratani, T., Kato, N., Akahane, M., Ohtomo, K., Minami, M., Omata, M.: Power Doppler sonography for hepatocellular carcinoma: factors affecting the power Doppler signals of the tumors. Liver 1998; 18: 427–433
Ishii, H., Okada, S., Okusaka, T., Yoshimori, M., Nakasuka, H., Shimada, K., Yamasaki, S., Nakanishi, Y., Sakamoto, M.: Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 1998; 82: 1638–1642
Ito, Y., Kojiro, M., Nakashima, T., Mori, T.: Pathomorphologic characteristics of 102 cases of thorotrast-related hepatocellular carcinoma, cholangiocarcinoma, and hepatic angiosarcoma. Cancer 1988; 62: 1153–1162
Izumi, N., Asahina, Y., Noguchi, O., Uchihara, M., Kanazawa, N., Itakura, J., Himeno, Y., Miyake, S., Sakai, T., Enomoto, N.: Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation. Cancer 2001; 91: 949–956
Kaibori, M., Matsui, Y., Yanagida, H., Yokoigawa, N., Kwon, A.H., Kamiyama, Y.: Positive status of alpha-fetoprotein and des-gammacarboxy prothrombin: important prognostic factor for recurrent hepatocellular carcinoma. World J. Surg. 2004; 28: 702–707
Kato, H., Nakamura, M., Muramatsu, M., Orito, E., Ueda, R., Mizokami, M.: Spontaneous regression of hepatocellular carcinoma: Two case reports and a literature review. Hepatol. Res. 2004; 29: 180–190
Katsushima, S., Inokuma, T., Oi, H., Okamura, J., Higashi, T., Takeuchi, R., Hidaka, A., Shigeno, C., Iida, Y., Konishi, J.: Acute hepatic failure following transcatheter arterial embolization for the treatment of hepatocellular carcinoma. Digestion 1997; 58: 189–195
Katyal, S., Oliver, J.H., Peterson, M.S., Ferris, J.V., Carr, B.S., Baron, R.L.: Extrahepatic metastases of hepatocellular carcinoma. Radiology 2000; 216: 698–703
Kawamoto, C., Ido, K., Isoda, N., Nagamine, N., Hozumi, M., Ono, K., Nakazawa, Y., Sato, Y., Kimura, K.: Prognosis of small hepatocellular carcinoma after laparoscopic ethanol injection. Gastrointest. Endosc. 1999; 50: 214–220
Kawasaki, S., Makuuchi, M., Miyagawa, S., Kakazu, T., Hayashi, K., Kasai, H., Miwa, S., Hui, A., Nishimaki, K.: Results of hepatic resection of hepatocellular carcinoma. World J. Surgery 1995; 19: 31–34
Kawata, S., Yamasaki, E., Nagase, T., Inui, Y., Ito, N., Matsuda, Y., Inada, M., Tamura, S., Noda, S., Imai, Y., Matsuzawa, Y.: Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial. Brit. J. Canc. 2001; 84: 886–891
Kettenbach, J., Kostler, W., Rucklinger, E., Gustorff, B., Wolf, F., Peer, K., Weigner, M., Lammer, J., Muller, W., Goldberg, S.N.: Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumours: Initial experience in 26 patients. Amer. J. Roentgenol. 2003; 180: 1537–1545
Kew, M.C.: Epidemiology of hepatocellular carcinoma. Toxicology 2002; 181: 35–38
Kew, M.C.: Virchow-Troisier’s lymph node in hepatocellular carcinoma. J. Clin. Gastroenterol. 1991; 13: 217–219
Khan, K.N., Yatsuhashi, H., Yamasaki, K., Yamasaki, M., Inoue, O., Koga, M., Yano, M.: Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J. Hepatol. 2000; 32: 269–278
Khan, M.A., Combs, C.S., Brunt, E.M., Lowe, V.J., Wolverson, M.K., Solomon, H., Collins, B.T., DiBisceglie, A.M.: Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J. Hepatol. 2000; 32: 792–797
Kim, C.K., Lim, J.H., Lee, W.J.: Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients. J. Ultrasound Med. 2001; 20: 99–104
Kim, R.D., Nazarey, P., Katz, E., Chari, R.S.: Laparoscopic staging and tumor ablation for hepatocellular carcinoma in Child C cirrhotics evaluated for orthotopic liver transplantation. Surg. Endosc. 2004; 18: 39–44
Koda, M., Murawaki, Y., Mitsuda, A., Ohyama, K., Horie, Y., Suou, T., Kawasaki, H., Ikawa, S.: Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer 2000; 88: 529–537
Koike, Y., Shiratori, Y., Sato, S., Obi, S., Teratani, T., Imamura, M., Yoshida, H., Shiina, S., Omata, M.: Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal vein invasion in patients with hepatocellular carcinoma — A prospective analysis of 227 patients. Cancer 2001; 91: 561–569
Kojiro, M.: “Nodule-in-nodule” appearance in hepatocellular carcinoma: Its significance as a morphologic marker of dedifferentiation. Intervirology 2004; 47: 179–183
Komorizomo, Y., Kohara, K., Oketani, M., Maeda, M., Shibathou, S., Shigenobu, S., Hiramine, Y., Yamasaki, N., Arima, T., Katzuaki, I., Arima, T.: Systemic combined chemotherapy with low dose of 5-fluorouracil, cisplatin, and interferon-alpha for advanced hepatocellular carcinoma. — A pilot study. Dig. Dis. Sci. 2003; 48: 877–881
Kouroumalis, E., Skordilis, P., Thermos, K., Vasilaki, A., Moschandrea, J., Manousos, O.N.: Treatment of hepatocellular carcinoma with octreotide: a randomized controlled study. Gut 1998; 42: 442–447
Krasner, N., Johnson, P.J., Portmann, B., Watkinson, G., MacSween, R.N.M., Williams, R.: Hepatocellular carcinoma in primary biliary cirrhosis: report of four cases. Gut 1979; 2: 255–258
Kwon, Y., Lee, S.K., Kim, J.S., Ro, J.Y., Yu, E.S.: Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules. Modern Pathol. 2002; 15: 1096–1101
Lai, E.C.-S., Ng, I.O.-L., Ng, M.M.-T., Lok, A.S.-F., Tam, P.-C., Fan, S.-T., Choi, T.-K., Wong, J.: Long-term results of resection for large hepatocellular carcinoma: a multivariate analysis of clinicopathological features. Hepatology 1990; 11: 815–818
Lau, W.Y., Leung, T.W.T., Ho, S.K.W., Chan, M., Lau, J., Chan, A.T.C., Yeo, W., Mok, T.S.K., Yu, S.C.H.: Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial. Lancet 1999; 353: 797–801
Lau, W.Y., Leung, T.W.T., Lai, B.S., Liew, C.T., Ho, S.K.W., Yu, S.C.H., Tang, A.M.Y.: Preoperative systemic chemoimmunotherapy and sequential resection for unresectable hepatocellular carcinoma. Ann. Surg. 2001; 233: 236–241
Lee, C.M., Hsu, C.Y., Eng, H.L., Huang, W.S., Lu, S.N., Changchien, C.S., Chen, C.L., Cho, C.L.: Telomerase activity and telomerase catalytic subunit in hepatocellular carcinoma. Hepato-Gastroenterol. 2004; 51: 796–800
Leung, T.W.T., Patt, Y.Z., Lau, W.Y., Ho, S.K.W., Yu, S.C.H., Chan, A.T.C., Mok, T.S.K., Yeo, W., Liew, C.T., Leung, N.W.Y., Tang, A.M.Y., Johnson, P.J.: Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clin. Canc. Res. 1999; 5: 1676–1681
Leung, W.T., Shiu, W.C., Leung, N., Chan, M., Tsao, M., Li, A.K., Metreweli, C.: Treatment of inoperative hepatocellular carcinoma by intra-arterial lipiodol and 4-epidoxorubicin. Canc. Chemother. Pharmacol. 1992; 29: 401–404
Liang, H.L., Yang, C.F., Pan, H.B., Lai, K.H., Cheng, J.S., Lo, G.H., Chen, C.K.H., Lai, P.H.: Small hepatocellular carcinoma: safety and efficacy of single high-dose percutaneous acetic acid injection for treatment. Radiology 2000: 214: 769–774
Limmer, J., Fleig, W.E., Leupold, D., Bittner, R., Ditschuneit, H., Beger, H.G.: Hepatocellular carcinoma in type I glycogen storage disease. Hepatology 1998; 8: 531–537
Lin, T.J., Liao, L.Y., Lin, C.L., Shih, L.S., Chang, T.A., Tu, H.Y., Chen, R.C., Wang, C.S.: Spontaneous regression of hepatocellular carcinoma: A case report and literature review. Hepato-Gastroenterol. 2004; 51: 579–582
Livraghi, T., Giorgio, A., Marin, G., Salmi, A., de Sio, I., Bolondi, L., Pompili, M., Brunello, F., Lazzaroni, S., Torzilli, G., Zucchi, A.: Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197: 101–108
Livraghi, T., Goldberg, S.N., Lazzaroni, F., Meloni, F., Solbiati, L., Gazelle, G.S.: Small hepatocellular carcinoma: Treatment with radiofrequency ablation versus ethanol injection. Radiology 1999; 210: 655–661
Llovet, J.M., Bru, C., Bruix, J.: Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin. Liver Dis. 1999; 19: 329–338
Llovet, J.M., Fuster, J., Bruix, J.: Prognosis of hepatocellular carcinoma (review). Hepato-Gastroenterol. 2002; 49: 7–11
Llovet, J.M., Bruix, J.: Unresectable hepatocellular carcinoma: metaanalysis of arterial embolization. Radiology 2004; 230: 300–301
Lutwick, L.I.: Relation between aflatoxin, hepatitis-B virus, and hepatocellular carcinoma. Lancet 1979/I: 755–757
Maeda, T., Adachi, E., Kajiyama, K., Sugimachi, K., Tsuneyoshi, M.: Spindle cell hepatocellular carcinoma. A clinicopathological analysis of 15 cases. Cancer 1996; 77: 51–57
Magalotti, D., Gueli, C., Zoli, M.: Transient spontaneous regression of hepatocellular carcinoma. Hepato-Gastroenterology 1998; 45: 2369–2371
Marcato, N., Abergel, A., Alexandre, M., Boire, J.Y., Darcha, C., Duchene, B., Chipponi, J., Boyer, L., Viallet, J.F., Bommelaer, G.: Hepatocellular carcinoma in patients with cirrhosis: performance and semiology of magnetic resonance imaging and lipiodol computerized tomography. Gastroenterol. Clin. Biol. 1999; 23: 114–121
Mazzaferro, V., Regalia, E., Doci, R., Morabito, A., Gennari, L., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M.: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. New Engl. J. Med. 1996; 334: 693–699
Mazzanti, R., Arena, U., Pantaleo, P., Antonuzzo, L., Cipriani, G., Neri, B., Giordano, C., Lanini, F., Marchetti, S., Gentilini, P.: Survival and prognostic factors in patients with hepatocellular carcinoma treated by percutaneous ethanol injection: A 10-year experience. Can. J. Gastroenterol. 2004; 18: 611–618
Melia, W.M., Johnson, P.J., Neuberger, J.: Hepatocellular carcinoma in primary biliary cirrhosis: detection by α-fetoprotein estimation. Gastroenterology 1984; 87: 660–663
Michel, J., Suc, B., Montpeyroux, Hachemanne, S., Blanc, P., Domergue, J., Mouiel, J., Gouillat, C., Ducerf, C., Saric, J., Le Treut, Y.P., Fourtanier, G., Escat, J.: Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J. Hepatol. 1997; 26: 1274–1280
Miki, K., Makuuchi, M., Takayama, T., Matsukura, A., Minagawa, M., Kubota, K., Hirata, M.: Peritoneal seeding of hepatocellular carcinoma after ethanol injection therapy. Hepato-Gastroenterol. 2000; 47: 1428–1430
Misawa, K., Hata, Y., Manabe, K., Matsuoka, S., Saito, M., Takada, J., Sano, F.: Spontaneous regression of hepatocellular carcinoma. J. Gastroenterol. 1999; 34: 410–414
Mita, Y., Aoyagi, Y., Yanagi, M., Suda, T., Suzuki, Y., Asakura, H.: The usefulness of determining des-γ-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma. Cancer 1998; 82: 1643–1648
Miyamoto, M., Sudo, T., Kuyama, T.: Spontaneous rupture of hepatocellular carcinoma: a review of 172 Japanese cases. Amer. J. Gastroenterol. 1991; 86: 67–71
Mor, E., Tur Kaspa, R., Sheiner, P., Schwartz, M.: Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann. Intern. Med. 1998; 129: 643–653
Morimoto, Y., Kubo, S., Shuto, T., Tanaka, H., Hirohashi, K., Yamamoto, T., Yamada, R., Kinoshita, H.: Power Doppler ultrasonographic diagnosis of small hepatocellular carcinoma. Dig. Surg. 2002; 19: 379–387
Moritz, M.W., Shoji, M., Sicard, G.A., Shioda, R., DeSchyver, K.: Surgical therapy in two patients with pedunculated hepatocellular carcinoma. Arch. Surg. 1988; 123: 772–774
Nagasue, N., Ono, T., Yamanoi, A., Kohno, H., El-Assal, O.N., Taniura, H., Uchida, M.: Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. Brit. J. Surg. 2001; 88: 515–522
Nakamoto, Y., Guidotti, I.G., Kuhlen, C.V., Fowler, P., Chisari, F.V.: Immune pathogenesis of hepatocellular carcinoma. J. Exper. Med. 1998; 188: 341–350
Naoumov, N.V., Chokshi, S., Metivier, E., Maertens, G., Johnson, P.J., Williams, R.: Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis. J. Hepatol. 1997; 27: 331–336
Navarro, F., Taourel, P., Michel, J., Perney, P., Fabre, J.-M., Blanc, F., Domerque, J.: Diaphragmatic and subcutaneous seeding of hepatocellular carcinoma following fine-needle aspiration biopsy. Liver 1998; 18: 251–254
Nikfarjam, M., Christophi, C.: Interstitial laser thermotherapy for liver tumours (review). Brit. J. Surg. 2003; 90: 1033–1047
Ockner, R.K., Kaikaus, R.M., Bass, N.M.: Fatty-acid metabolism and the pathogenesis of hepatocellular carcinoma: review and hypothesis. Hepatology 1993; 18: 669–676
Ohmoto, K., Miyake, I., Tsuduki, M., Shibata, N., Takesue, M., Kunieda, T., Ohno, S., Kuboki, M., Yamamoto, S.: Percutaneous microwave coagulation therapy for unresectable hepatocellular carcinoma. Hepato-Gastroenterol. 1999; 46: 2894–2900
Ohnishi, K., Yoshioka, H., Kosaka, K., Toshima, K., Nishiyama, J., Kameda, C., Ito, S., Fujiwara, K.: Treatment of hypervascular small hepatocellular carcinoma with ultrasound-guided percutaneous acetic acid injection: comparison with segmental transcatheter arterial embolization. Amer. J. Gastroenterol. 1996; 91: 2574–2579
Okuda, H., Nakanishi, T., Takatsu, K., Saito, A., Hayashi, N., Takasaki, K., Takenami, K., Yamamoto, M., Nakano, M.: Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma. Cancer 2000; 88: 544–549
Orlando, A., Cottone, M., Virdone, R., Parisi, P., Sciarrino, E., Maringhini, A., Caltagirone, M., Simonetti, R.G., Pagliaro, L.: Treatment of small hepatocellular carcinoma associated with cirrhosis by percutaneous ethanol injection. A trial with a comparison group. Scand. J. Gastroenterol. 1997; 32: 598–603
Ozturk, M.: Genetic aspects of hepatocellular carcinogenesis. Semin. Liver Dis. 1999; 19: 235–242
Pacella, C.M., Bizzari, G., Cecconi, P., Caspani, B., Magnolfi, F., Bianchini, A., Anelli, V., Pacella, S., Rossi, Z.: Hepatocellular carcinoma: long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization. Radiology 2001; 219: 669–678
Palmieri, G.B.E., Morabito, A., Rea, A., Gravina, A., Bianco, A.R.: Thymostimulin treatment of hepatocellular carcinoma in liver cirrhosis. Int. J. Canc. 1996; 8: 827–832
Pirisi, M., Avellini, C., Fabris, C., Scott, C., Bardus, P., Soardo, G., Beltrami, C.A., Bartoli, E.: Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study. Cancer Res. Clin. Oncol. 1998; 124: 397–400
Pompili, M., Rapaccini, G.L., de Luca, F., Caturelli, E., Astone, A., Siena, D.A., Villani, M.R., Grattagliano, A., Cedrone, A., Gasbarrini, G.: Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection. Cancer 1997; 79: 1501–1508
Poo, J.L., Rosas-Romero, R., Montemayor, A.C., Isoard, F., Uribe, M.: Diagnostic value of the copper/zinc ratio hepatocellular carcinoma: a case control study. J. Gastroenterol. 2003; 38: 45–51
Poon, R.T.P., Fan, S.T., Wong, J.: Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J. Amer. Coll. Surg. 2002; 194: 592–602
Poon, R.T.P., Yu, W.C., Fan, S.T., Wong, J.: Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: A randomized trial. Aliment. Pharm. Ther. 2004; 19: 779–788
Raoul, J.L., Messner, M., Boucher, E., Bretagne, J.F., Campion, J.P., Boudjema, K.: Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of (131)J-labelled lipiodol. Brit. J. Surg. 2003; 90: 1379–1383
Rogiers, X., Knoefel, W.T., Malago, M., Sterneck, M., Broelsch, C.E.: Liver transplantation for hepatocellular carcinoma. Dig. Surg. 1995; 12: 61–64
Rose, D.M., Chapman, W.C., Brockenbrough, A.T., Wright, J.K., Rose, A.T., Meranze, S., Mazer, M., Blair, T., Blanke, C.D., Debelak, J.P., Wright Pinson, C.: Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma. Amer. J. Surg. 1999; 177: 405–410
Samonakis, D.N., Koutroubakis, I.E., Sfiridaki, A., Malliaraki, N., Antoniou, P., Romanos, J., Kouroumalis, E.A.: Hypercoagulable states in patients with hepatocellular carcinoma. Dig. Dis. Sci. 2004; 49: 854–858
Santambrogio, R., Podda, M., Zuin, M., Bertolini, E., Bruno, S., Cornalba, G.P., Costa, M., Montorsi, M.: Safety and efficacy of laparoscopic radiofrequency of hepatocellular carcinoma in patients with liver cirrhosis. Surg. Endosc. 2003; 17: 1826–1832
Saurin, J.C., Tanière, P., Mion, F., Jacob, P., Partensky, C., Paliard, P., Berger, F.: Primary hepatocellular carcinoma in workers exposed to vinyl chloride. A report of two cases. Cancer 1997; 79: 1671–1677
Seki, T., Tamai, T., Nakagawa, T., Imamura, M., Nishimura, A., Yamashiki, N., Ikeda, K., Inoue, K.: Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer 2000; 89: 1245–1251
Shepherd, F.A., Rotstein, L.E., Houle, S., Yip, T.C.K., Paul, K., Suiderman, K.W.: A phase 1 dose escalation trial of yttrium90 microspheres in the treatment of primary hepatocellular carcinoma. Cancer 1992; 70: 2250–2254
Sherlock, S., Fox, R.A., Niazi, S.P., Scheuer, P.J.: Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet 1970/I: 1243–1247
Sherman, M., Takayama, Y.: Screening and treatment for hepatocellular carcinoma. Gastroenterol. Clin. N. Amer. 2004; 33: 671–691
Shetty, K., Timmins, K., Brensinger, C., Furth, E.E., Rattan, S., Sun, W.J., Rosen, M., Soulen, M., Shaked, A., Reddy, K.R., Olthoff, K.M.: Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transplant. 2004; 10: 911–918
Shimada, M., Takenaka, K., Fujiwara, Y., Gion, T., Kajiyama, K., Maeda, T., Shirabe, K., Sugimachi, K.: Des-γ-carboxy prothrombin and α-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma. Cancer 1996; 78: 2094–2100
Shimizu, A., Koyama, M., Okuda, Y., Takase, K., Nakano, T., Tameda, Y.: Hepatocellular carcinoma in primary biliary cirrhosis: A case report and review of the Japanese literature. Hepato-Gastroenterology 1998; 45: 2352–2355
Shiomi, S., Nishiguchi, S., Ishizu, H., Iwata, Y., Sasaki, N., Tamori, A., Habu, D., Takeda, T., Kubo, S., Ochi, H.: Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma. Amer. J. Gastroenterol. 2001; 96: 1877–1880
Shiraki, K., Shimizu, A., Takase, K., Suzuki, A., Tameda, Y., Nakano, T.: Prospective study of laparoscopic findings with regard to the development of hepatocellular carcinoma in patients with hepatitis C virusassociated cirrhosis. Gastrointest. Endosc. 2001; 53: 449–455
Srinivasan, P., McCall, J., Pritchard, J., Dhawan, A., Baker, A., Vergani, G.M., Muriesan, P., Rela, M., Heaton, N.D.: Orthotopic liver transplantation for unresectable hepatoblastoma. Transplantation 2002; 74: 652–655
Stickel, F., Schuppan, D., Hahn, E.G., Seitz, H.K.: Cocarcinogenic effects of alcohol in hepatocarcinogenesis. Gut 2002; 51: 132–139
Sugiyama, M., Sakahara, H., Torizuka, T., Kanno, T., Nakamura, F., Futatsubashi, M., Nakamura, S.: (18)F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma. J. Gastroenterol. 2004; 39: 961–968
Taieb, J., Bonyhay, L., Golli, L., Ducreux, M., Boleslawski, E., Tigaud, J.M., de Baere, T., Mansourbakht, T., Delgado, M.A., Hannoun, L., Poynard, T., Boige, V.: Gemcitabine plus Oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules. Cancer 2003; 98: 2664–2670
Takeda, Y., Togashi, H., Shinzawa, H., Miyano, S., Ishii, R., Karasawa, T., Takeda, Y., Saito, T., Saito, K., Haga, H., Matsuo, T., Aoki, M., Mitsuhashi, H., Watanabe, H., Takahashi, T.: Spontaneous regression of hepatocellular carcinoma and review of literature. J. Gastroenterol. Hepatol. 2000; 15: 1079–1086
Tamburro, C.H., Lee, H.M.: Primary hepatic cancer in alcoholics. Clin. Gastroenterol. 1981; 10: 457–477
Tanaka, Y., Mizokami, M., Kato, T., Matsumoto, Y., Ishihama, T., Sugauchi, F., Suzuki, S., Miyata, N.: GB virus C/hepatitis C virus infection among patients with hepatocellular carcinoma. Hepatol. Res. 1997; 8: 44–51
Torimura, T., Ueno, T., Kin, M., Harada, R., Taniguchi, E., Nakamura, T., Sakata, R., Hashimoto, O., Sakamoto, M., Kumashiro, R., Sata, M., Nakashima, O., Yano, H., Kojiro, M.: Overexpression of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma. J. Hepatol. 2004; 40: 799–807
Trenn, G., Utz, D., Reis, H.E.: Spontaneous remission of a hepatocellular carcinoma. Onkologie 1998; 21: 156–159
Tsai, J.-F., Chang, W.-Y., Jeng, J.-E., Ho, M.-S., Lin, Z.-Y., Tsai, J.-H.: Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver 1994; 14: 98–102
Tsai, J.F., Chuang, L.Y., Jeng, J.E., Ho, M.S., Hsieh, M.Y., Lin, Z.Y., Wang, L.Y.: Betel quid chewing as a risk factor for hepatocellular carcinoma: a case control study. Brit. J. Canc. 2001; 84: 709–713
Vana, J., Murphy, G.P., Aronoff, B.L., Baker, H.W.: Primary liver tumors and oral contraceptives. Results of a survey. J. Amer. Med. Ass. 1977; 238: 2154–2158
Ward, J., Guthrie, J.A., Scott, D.J., Atchley, J., Wilson, D., Davies, M.H., Wyatt, J.I., Robinson, P.J.: Hepatocellular carcinoma in the cirrhotic liver: Double-contrast MR imaging for diagnosis. Radiology 2000; 216: 154–162
Weinberg, A.G., Mize, C.E., Worthan, H.G.: The occurrence of hepatoma in the chronic form of hereditary tyrosinemia. J. Pediatr. 1976; 88: 434–438
Wilkinson, M.L., Portmann, B., Williams, R.: Wilson’s disease and hepatocellular carcinoma: possible protective role of copper. Gut 1983; 24: 767–771
Winston, C.B., Schwartz, L.H., Fong, Y.M., Blumgart, L.H., Panicek, D.M.: Hepatocellular carcinoma: MR imaging findings in cirrhotic livers and noncirrhotic livers. Radiology 1999; 210: 75–79
Wogan, G.N.: Aflatoxins as risk factors for hepatocellular carcinoma in humans. Canc. Res. 1992; 52: 2114–2118
Wong, W.S., Patel, S.C., Cruz, F.S., Gala, K.V., Turner, A.F.: Cryosurgery as a treatment for advanced stage hepatocellular carcinoma. Cancer 1998; 82: 1268–1278
Yamada, R., Kishi, K., Sato, M., Sonomura, T., Nishida, N., Tanaka, K., Shioyama, Y., Terada, M., Kimura, M.: Transcatheter aterial chemoembolization (TACE) in the treatment of unresectable liver cancer. World J. Surgery 1995; 19: 795–800
Yamamoto, K., Masuzawa, M., Karo, M., Kurosawa, K., Kaneko, A., Ishida, H., Imamura, E., Park, N.J., Shirai, Y., Fujimoto, K., Michida, T., Hayashi, N., Ikeda, M.: Evaluation of combined therapy with chemoembolization and ethanol injection for advanced hepatocellular carcinoma. Semin. Oncol. 1997; 24(Suppl. 6): 50–55
Yeh, C.N., Lee, W.C., Jeng, L.B., Chen, M.F.: Pedunculated hepatocellular carcinoma: Clinicopathologic study of 18 surgically resected cases. World J. Surg. 2002; 28: 1133–1138
Yuki, K., Hirohashi, S., Sakamoto, M., Kanai, T., Shimosato, Y.: Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases. Cancer 1990; 66: 2174–2179
Zangos, S., Gille, T., Eichler, K., Engelmann, K., Woitaschek, D., Balzer, J.O., Mack, M.G., Thalhammer, A., Vogl, T.J.: Transarterial chemoembolization in hepatocellular carcinoma: technique, indications, results. Radiologe 2001; 41: 906–914
Zheng, R.Q., Zhou, P., Kudo, M.: Hepatocellular carcinoma with nodule-in-nodule appearance: Demonstration by contrast-enhanced coded phase inversion harmonic imaging. Intervirology 2004; 47: 184–190
Zhou, X.D., Tang, Z.Y., Yang, B.H., Lin, Z.Y., Ma, Z.C., Ye, S.L., Wu, Z.Q., Fan, J., Qin, L.X., Zheng, B.H.: Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer 2001; 91: 1479–1486
Fibrolamellar carcinoma
Berman, M.A., Burnham, J.A., Sheahan, D.G.: Fibrolamellar carcinoma of the liver. An immunohistochemical study of nineteen cases and a review of the literature. Hum. Pathol. 1988; 19: 784–794
Brandt, D.J., Johnson, C.D., Stephens, D.H., Weiland, L.H.: Imaging of fibrolamellar hepatocellular carcinoma. Amer. J. Radiol. 1988; 151: 295–299
Chang, Y.C., Dai, Y.C., Chow, N.H.: Fibrolamellar hepatocellular carcinoma with a recurrence of classic hepatocellular carcinoma: a case report and review of oriental cases. Hepato-Gastroenterol. 2003; 50: 1637–1640
Hui, M.-S., Choi, W.-M., Perng, H.-L., Chen, L.-K., Yang, K.-C., Chen, T.-F.: Fibrolamellar hepatocellular carcinoma — an atypical MR manifestation. Hepato-Gastroenterol. 1998; 45: 514–517
Ichikawa, T., Federle, M.P., Grazioli, L., Marsh, W.: Fibrolamellar hepatocellular carcinoma: pre-and posttherapy evaluation with CT and MR imaging. Radiology 2000; 217: 145–151
Katzenstein, H.M., Krailo, M.D., Malogolowkin, M.H., Ortega, J.A., Qu, W.C., Douglass, E.C., Feusner, J.H., Reynolds, M., Quinn, J.J., Newman, K., Finegold, M.J., Haas, J.E., Sensel, M.G., Castleberry, R.P., Bowman, L.C.: Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 2003; 97: 2006–2012
Martinez Isla, A., Ferrara, A., Badia, J.M., Holloway, I., Tanaka, H., Riaz, A., Habib, N.A.: Fibrolamellar hepatocellular carcinoma: results of partial liver resection. Rev. Esp. Enf. Digest. 1997; 89: 703–705
Pinna, A.D., Iwatsuki, S., Lee, R.G., Todo, S., Madariaga, J.R., Marsh, J.W., Casavilla, A., Dvorchik, I., Fung, J.J., Starzl, T.E.: Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 1997; 26: 877–883
Soreide, O., Czerniak, Al, Bradpiece, H., Bloom, S., Blumgart, L.: Characteristics of fibrolamellar hepatocellular carcinoma. A study of nine cases and a review of the literature. Amer. J. Surg. 1986; 151: 518–523
Starzl, T.E., Iwatsuki, S., Shaw jr., B.W., Nalesnik, M.A., Farhi, D.C., van Thiel, D.H.: Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg. Gyn. Obstetr. 1986; 162: 145–148
Vecchio, F.M.: Fibrolamellar carcinoma of the liver: a distinct entity within the hepatocellular tumors. A review. Appl. Pathol. 1988; 6: 139–148
Yamaguchi, R., Tajika, T., Kanda, H., Nakanishi, K., Kawanishi, J.: Fibrolamellar carcinoma of the liver. Hepato-Gastroenterology 1999; 46: 1706–1709
Yoshimi, F., Asato, Y., Amemiya, R., Itabashi, M., Nakamura, K.: Fibrolamellar hepatocellular carcinoma in a Japanese man: Report of a case. Surg. Today 2002; 32: 174–179
Cholangiocellular carcinoma
Aishima, S., Asayama, Y., Taguchi, K., Sugimachi, K., Shirabe, K., Shimada, M., Sugimachi, K., Tsuneyoshi, M.: The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma. Mod. Pathol. 2002; 15: 1181–1190
Aishima, S., Matsuura, S., Terashi, T., Taguchi, K., Shimada, M., Maehara, Y., Tsuneyoshi, M.: Aberrant expression of laminin gamma 2 chain and its prognostic significance in intrahepatic cholangiocarcinoma according to growth morphology. Mod. Pathol. 2003; 17: 938–945
Chen, M.-F., Jan, Y.-Y., Chen, T.-C.: Clinical studies of mucin-producing cholangiocellular carcinoma. Ann. Surg. 1998; 227: 63–69
Chu, K.-M., Lai, E.C.S., Al-Hadeedi, S., Arciall, jr., C.E., Lo, C.-M., Liu, C.-L., Fan, S.-T., Wong, J.: Intrahepatic cholangiocarcinoma. World J. Surg. 1997; 21: 301–306
Goto, N., Yasuda, I., Uematsu, T., Kanemura, N., Takai, S., Ando, K., Kato, T., Osada, S., Takao, H., Saji, S., Shimokawa, K., Moriwaki, H.: Intrahepatic cholangiocarcinoma arising 10 years after the excision of congenital extrahepatic biliary dilation. J. Gastroenterol. 2001; 36: 856–862
Harrison, L.E., Fong, Y., Klimstra, D.S., Zee, S.Y., Blumgart, L.H.: Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma. Brit. J. Surg. 1998; 85: 1068–1070
Haswell-Elkins, M.R., Satarug, S., Elkins, D.B.: Opisthorchis viverrini infection in northeast Thailand and its relationship to cholangiocarcinoma. J. Gastroenterol. Hepatol. 1992; 7: 538–548
Hirohashi, K., Uenishi, T., Kubo, S., Yamamoto, T., Tanaka, H., Shuto, T., Kinoshita, H.: Macroscopic types of intrahepatic cholangiocarcinoma: Clinicopathologic features and surgical outcome. Hepato-Gastroenterol. 2002; 49: 326–329
Klatskin, G.: Adenocarcinoma of the hepatic duct and its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Amer. J. Med. 1965; 38: 241–256
Kubo, S., Uenishi, T., Yamamoto, S., Hai, S., Yamamoto, K., Ogawa, M., Takemura, S., Shuto, T., Tanaka, H., Yamazaki, O., Hirohashi, K., Kinoshita, H.: Clinicopathologic characteristics of small intrahepatic cholangiocarcinomas of mass-forming type. Hepatol. Res. 2004; 29: 223–227
Lim, J.H.: Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. Amer. J. Roentgenol. 2003; 181: 819–827
Okami, J., Dono, K., Sakon, M., Tsujie, M., Hayashi, N., Fujiwara, Y., Nagano, H., Umeshita, K., Nakamori, S., Monden, M.: Patterns of regional lymph node involvement in intrahepatic cholangiocarcinoma of the left lobe. J. Gastrointestin. Surg. 2003; 7: 850–856
Polizos, A., Kelekis, N., Sinani, C., Patsiaoura, G., Papadamou, G., Dalekos, G.N.: Advanced intrahepatic cholangiocarcinoma in hepatitis C virus-related decompensated cirrhosis: Case report and review of the literature. Eur. J. Gastroenterol. Hepatol. 2003; 15: 331–334
Ramage, J.K., Donaghy, A., Farrant, J.M., Iorns, R., Williams, R.: Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995; 108: 865–869
Rizzi, P.M., Ryder, S.D., Portmann, B., Ramage, J.K., Naoumov, N.V., Williams, R.: p53 protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis. Gut. 1996; 38: 265–268
Roayaie, S., Guarrera, J.V., Ye, M.Q., Thung, S.N., Emre, S., Fishbein, T.M., Guy, S.R., Sheiner, P.A., Miller, C.M., Schwartz, M.E.: Aggressive surgical treatment of intrahepatic cholangiocarcinoma: Predictors of outcomes. J. Amer. Coll. Surg. 1998; 187: 365–372
Sasaki, A., Kawano, K., Aramaki, M., Ohno, T., Tahara, K., Kitano, S.: Correlation between tumor size and mode of spread in mass-forming intrahepatic cholangiocarcinoma. Hepato-Gastroenterol. 2004; 51: 224–228
Shiraishi, M., Takushi, Y., Simoji, H., Oshiro, T., Shinzato, S., Tanigawa, N., Kusano, T., Muto, Y.: Combined hepatocellular and cholangiocellular carcinoma in a non-cirrhotic liver. J. Gastroenterol. 1998; 33: 593–596
Soyer, P., Bluemke, D.A., Hruban, R.H., Sitzmann, J.V., Fishman, E.K.: Intrahepatic cholangiocarcinoma: findings on spiral CT during arterial portography. Eur. J. Radiol. 1994; 19: 37–42
Valls, C., Guma, A., Puig, I., Sanchez, A., Andia, E., Serrano, T., Figueras, J.: Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom. Imag. 2000; 25: 490–496
Yoshimoto, H., Ikeda, S., Tanaka, M., Matsumoto, S.: Intrahepatic cholangiocarcinoma associated with hepatolithiasis. Gastrointest. Endosc. 1985; 31: 260–263
Mucoepidermoid carcinoma
Choi, D., Kim, H., Lee, K.S., Lee, K.G., Park, C.K.: Mucoepidermoid carcinoma of the liver diagnosed as a liver abscess: report of a case. Surg. Today 2004; 34: 968–972
De Lajarte-Thirouard, A.S., Rioux-Leclercq, N., Boudjema, K., Gandon, Y., Ramee, M.P., Turlin, B.: Squamous cell carcinoma arising in a hepatic forgut cyst (case report). Pathol. Res. Pract. 2002; 198: 697–700
Kang, H.Y., Park, Y.N., Kim, S.E., Sohn, K.R., Yoo, N.C., Park, J.Y., Kim, K.S., Park, C.: Double primary mucoepidermoid carcinoma and hepatocellular carcinoma of the liver. A case report. Hepato-Gastroenterol. 2003; 50: 238–241
Maeda, T., Takenaka, K., Taguchi, K., Kajiyama, K., Shirabe, K., Shimada, M., Tsuneyoshi, M., Sugimachi, K.: Adenosquamous carcinoma of the liver. Clinicopathologic characteristics and cytokeratin profile. Cancer 1997; 80: 364–371
Monteagudo, M., Vidal, G., Moreno, M., Bella, R., Diaz, M.J., Colomer, O., Santesmasses, A.: Squamous cell carcinoma and infection in a solitary hepatic cyst. Eur. J. Gastroenterol. Hepatol. 1998; 10: 1051–1053
Pianzola, L.E., Drut, R.: Mucoepidermoid carcinoma of the liver. Amer. J. Clin. Pathol. 1971; 56: 758–761
Yagi, H., Ueda, M., Kawachi, S., Tanabe, M., Aiura, K., Wakabayashi, G., Shimazu, M., Sakamoto, M., Kitajima, M.: Squamous cell carcinoma of the liver originating from non-parasitic cysts after a 15 year follow-up (case report). Eur. J. Gastroenterol. Hepatol. 2004; 16: 1051–1056
Yeh, C.-N., Jan, Y.-Y., Chen, M.-F.: Adenosquamous carcinoma of the liver: Clinicopathologic study of 10 surgically treated cases. World J. Surg. 2003; 27: 168–172
Biliary cystadenocarcinoma
Choi, B.I., Lim, J.H., Han, M.C., Lee, D.H., Kim, S.H., Kim, Y.I., Kim, C.-W.: Biliary cystadenoma and cystadenocarcinoma: CT and sonographic findings. Radiology 1989; 171: 57–61
Devaney, K., Goodman, Z.D., Ishak, K.G.: Hepatobiliary cystadenoma and cystadenocarcinoma. A light and microscopic and immunohistochemical study of 70 patients. Amer. J. Surg. Pathol. 1994; 18: 1078–1091
Horsmans, Y., Laka, A., van Beers, B.E., Descamps, C., Gigot, J.F., Geupel, A.P.: Hepatobiliary cystadenocarcinoma without ovarian stroma and normal CA 19-9 levels. Dig. Dis. Sci. 1997; 42: 1406–1408
Kinoshita, H., Tanimura, H., Onishi, H., Kasano, Y., Uchiyama, K., Yamaue, H.: Clinical features and imaging diagnosis of biliary cystadenocarcinoma of the liver. Hepato-Gastroenterol. 2001; 48: 250–252
Kubota, E., Katsumi, K., Iida, M., Kishimoto, A., Ban, Y., Nakata, K., Takahashi, N., Kobayashi, K., Andoh, K., Takamatsu, S., Joh, T.: Biliary cystadenocarcinoma followed up as benign cystadenoma for 10 years (case report). J. Gastroenterol. 2003; 38: 278–282
Sato, M., Watanabe, Y., Tokui, K., Kohtani, T., Nakata, Y., Chen, Y., Kawachi, K.: Hepatobiliary cystadenocarcinoma connected to the hepatic duct: a case report and review of the literature. Hepato-Gastroenterol. 2003; 50: 1621–1624
Shrikhande, S., Kleeff, J., Adyanthaya, K., Zimmermann, A., Shrikhande, V.: Management of hepatobiliary cystadenocarcinoma. Dig. Surg. 2003; 20: 60–63
Wee, A., Nilsson, B., Kang, J.Y., Tan, L.K., Rauff, A.: Biliary cystadenocarcinoma arising in a cystadenoma. Report of a case diagnosed by fine needle aspiration cytology. Acta Cytol. 1993; 37: 966–970
Hepatoblastoma
Bernstein, I.T., Bulow, S., Mauritzen, K.: Hepatoblastoma in two cousins in a family with adenomatous polyposis. Report of two cases. Dis. Colon Rectum 1992; 35: 373–374
Boechat, M.I., Kangarloo, H., Ortega, J., Hall, T., Feig, St., Stanley, P., Gilsanz, V.: Primary liver tumors in children: comparison of CT and MR imaging. Radiology 1988; 169: 727–732
Edmondson, H.A.: Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood. Amer. J. Dis. Child. 1956; 91: 168–189
Fish, J.C., McCary, R.G.: Primary cancer of the liver in childhood. Arch. Surg. 1966; 93: 355–359
Koneru, B., Flye, M.W., Busuttil, R.W., Shaw, B.W., Lorber, M.I., Emond, J.C., Kalayoglu, M., Freese, D.K., Starzl, T.E.: Liver transplantation for hepatoblastoma. The American experience. Ann. Surg. 1991; 213: 118–121
Manivel, C., Wick, M.R., Abenoza, P., Dehner, L.P.: Teratoid hepatoblastoma. The nosologic dilemma of solid embryonic neoplasms of childhood. Cancer 1986; 57: 2168–2174
Steiner, M.M.: Primary carcinoma of the liver in childhood. Report of two cases, with a critical review of the literatur. Amer. J. Dis. Child. 1938; 55: 807–824
Weinberg, A.G., Feingold, M.J.: Primary hepatic tumors of childhood. Hum. Pathol. 1983; 14: 512–537
Yamazaki, M., Ryu, M., Okazumi, S., Kondo, F., Cho, A., Okada, T., Takayama, W., Kawashima, T., Furuki, A., Hirata, T.: Hepatoblastoma in an adult — a case report and clinical review of literature. Hepatol. Res. 2004; 30: 82–188
Embryonal sarcoma
Buetow, P.C., Buck, J.L., Pantongrag-Brown, L., Marshall, W.H., Ros, P.R., Levine, M.S., Goodman, Z.D.: Undifferentiated (embryonal) sarcoma of the liver. Pathologic basis of imaging findings in 28 cases. Radiology 1997; 203: 779–783
Houry, S., Gharbi, L., Huguier, M., Callard, P., André, T.: Undifferentiated embryonal sarcoma in the liver of adults. Presse Med. 1998; 27: 518–520
Lauwers, G.Y., Grant, L.D., Donnelly, W.H., Meloni, A.M., Foss, R.M., Sanberg, A.A., Langham, M.R.: Hepatic undifferentiated (embryonal) sarcoma arising in a mesenchymal hamartoma. Amer. J. Surg. Pathol. 1997; 21: 1248–1254
Leuschner, I., Schmidt, D., Harms, D.: Undifferentiated sarcoma of the liver in childhood: morphology, flow cytometry and literature review. Hum. Pathol. 1990; 21: 68–76
Stocker, J.T., Ishak, K.G.: Undifferentiated (embryonal) sarcoma of the liver. Report of 31 cases. Cancer 1978; 42: 336–348
Walker, N.I., Horn, M.J., Strong, R.W., Lynch, S.V., Cohen, J., Ong, T.H., Harris, O.D.: Undifferentiated (embryonal) sarcoma of the liver. Pathologic findings and long-term survival after complete surgical resection. Cancer 1992; 69: 52–59
Webber, E.M., Morrison, K.B., Pritchard, S.L., Sorensen, P.H.B.: Undifferentiated embryonal sarcoma of the liver: results of clinical management in one center. J. Pediatr. Surg. 1999; 34: 1641–1644
Epithelioid haemangioendothelioma
Demetris, A.J., Minervini, M., Raikow, R.B., Lee, R.G.: Hepatic epithelioid hemangioendothelioma. Amer. J. Surg. Pathol. 1997; 21: 263–270
Den Bakker, M.A., den Bakker, A.J., Beenen, R., Mulder, A.H., Eulderink, F.: Subtotal liver calcification due to epithelioid hemangioendothelioma. Path. Res. Pract. 1998; 194: 189–195
Dietze, O., Davies, S.E., Williams, R., Portmann, B.: Malignant epithelioid hemangioendothelioma of the liver: A clinicopathological and histochemical study of 12 cases. Histopathology 1989; 15: 225–237
Furuta, K., Sodeyama, T., Usuda, S, Yoshizawa, K., Kiyosawa, K., Furuta, S., Imai, Y., Itoh, N., Fukuzawa, M., Hotchi, M.: Epithelioid hemangioendothelioma of the liver diagnosed by liver biopsy under laparoscopy. Amer. J. Gastroenterol. 1992; 87: 797–800
Ishak, K.G., Sesterhenn, I.A., Goodman, M.Z.D., Rabin, L., Stromeyer, F.W.: Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases. Hum. Pathol. 1984; 15: 839–852
Kayler, L.K., Merion, R.M., Arenas, J.D., Magee, J.C., Campbell, D.A., Rudich, S.M., Punch, J.D.: Epithelioid hemangioendothelioma of the liver disseminated to the peritoneum treated with liver transplantation and interferon alpha-2b. Transplantation 2002; 74: 128–130
Kelleher, M.B., Iwatsuki, S., Sheahan, D.G.: Epithelioid hemangioendothelioma of liver: clinicopathological correlation of 10 cases treated by orthotopic liver transplantation. Amer. J. Surg. Pathol. 1989; 13: 999–1008
Lyburn, I.D., Torreggiani, W.C., Harris, A.C., Zwirewich, C.V., Buckley, A.R., Davis, J.E., Chung, S.W., Scudamore, C.H., Ho, S.G.F.: Hepatic epithelioid hemangioendothelioma: sonographic, CT, and MRT imaging appearances. Amer. J. Roentgenol. 2003; 180: 1359–1364
Makhlouf, H.R., Ishak, K.G., Goodman, Z.D.: Epitheloid hemangioendothelioma of the liver. A clinicopathologic study of 137 cases. Cancer 1999; 85: 562–582
Malamut, G., Perlemuter, G., Buffet, C., Bedossa, P., Joly, J.P., Colombat, M., Kuoch, V., Pelletier, G.: Epithelioid hemangioendothelioma in a patient with nodular regenerative hyperplasia. Gastroenterol. Clin. Biol. 2001; 25: 1105–1107
Marino, I.R., Todo, S., Tzakis, A.G., Klintmalm, G., Kelleher, M., Iwatsuki, S., Starzl, T.E., Esquivel, C.O.: Treatment of hepatic epithelioid hemangioendothelioma with liver transplantation. Cancer 1988; 62: 2079–2084
Mermuys, K., Vanhoenacker, P.K., Roskams, T., Dhaenens, P., Van Hoe, L.: Epithelioid hemangioendothelioma of the liver: Radiologic-pathologic correlation. Abdom. Imag. 2004; 29: 221–223
Miller, W.J., Dodd, G.D., Federle, M.P., Baron, R.L.: Epitheloid hemangioendothelioma of the liver: imaging findings with pathologic correlation. Amer. J. Roentg. 1992; 159: 53–57
Walsh, M.M., Hytiroglou, P., Thung, S.N., Fiel, I., Siegel, D., Emre, S., Ishak, K.G.: Epithelioid hemangioendothelioma of the liver mimicking Budd-Chiari syndrome. Arch. Pathol. Lab. Med. 1998; 122: 846–848
Angiosarcoma
Awan, S., Davenport, M., Portmann, B., Howard, E.R.: Angiosarcoma of the liver in children. J. Pediatr. Surg. 1996; 31: 1729–1732
Falk, H., Thomas, L.B., Popper, H., Ishak, K.G.: Hepatic angiosarcoma associated with androgenic-anabolic steroids. Lancet 1979/II: 1120–1123
Hertzanu, Y., Peiser, J., Zirkin, H.: Massive bleeding after fine needle aspiration of liver angiosarcoma. Gastrointest. Radiol. 1990; 15: 42–46
Kojiro, M., Nakashima, T., Ito, Y., Ikezaki, H., Moni, T., Kido, C.: Thorium dioxide-related angiosarcoma of the liver: Pathomorphologic study of 29 autopsy cases. Arch. Path. Lab. Med. 1985; 109: 853–857
Koyama, T., Fletcher, J.G., Johnson, C.D., Kuo, M.S., Notohara, K., Burgart, L.J.: Primary hepatic angiosarcoma: Findings at CT and MR imaging. Radiology 2002; 222: 667–673
Mark, L., Delorme, F., Creech, J.L., Odgen, L.L., Fadell, E.H., Songster, C.L., Clanton, J., Johnson, M.N., Christopherson, W.M.: Clinical and morphological features of hepatic angiosarcoma in vinyl chloride workers. Cancer 1976; 37: 149–163
Molina, E., Hernandez, A.: Clinical manifestations of primary hepatic angiosarcoma. Dig. Dis. Sci. 2003; 48: 677–682
Salgado, M., Sans, M., Forns, X., Bruguera, M., Castells, A., Navasa, M., Rodes, J.: Hepatic angiosarcoma: A report of a case associated treatment with arsenic salts and a review of the literature. Gastroenterol. Hepatol. 1995; 18: 132–135
Leiomyosarcoma
Baur, M., Pötzi, R., Lochs, H., Neuhold, N., Walgram, M., Gangl, A.: Primary leiomyosarcoma of the liver — a case report. Z. Gastroenterol. 1993; 31: 20–23
Celdran, A., Frieyro, O., del Rio, A., Franco, A., Bosch, O., Sarasa, J.L.: Leiomyosarcoma of the portal venous system: A case report and review of literature. Surgery 2004; 135: 455–456
Cioffi, U., Quattrone, P., de Simone, M., Bonavia, L., Segalin, A., Masini, T., Montorsi, M.: Primary multiple epithelioid leiomyosarcoma of the liver. Hepato-Gastroenterol. 1996; 43: 1603–1605
Civardi, G., Cavanna, L., Iovine, E., Buscarini, E., Vallisa, D., Buscarini, L.: Diagnostic imaging of primary hepatic leiomyosarcoma: A case report. Ital. J. Gastroenterol. 1996; 28: 98–101
Griffin, A.S., Sterchi, J.M.: Primary leiomyosarcoma of the inferior vena cava: a case report and review of the literature. J. Surg. Oncol. 1987; 34: 53–60
Maki, H.S., Hubert, B.C., Sajjad, S.M., Kirchner, J.P., Kuehner, M.E.: Primary hepatic leiomyosarcoma. Arch. Surg. 1987; 122: 1193–1196
Rhabdomyosarcoma
Burrig, K.F., Knauer, S.: Rhabdomyosarcoma of the liver in adulthood. Case report and review of the literature. Pathologe 1994; 15: 54–57
Cote, R.J., Urmacher, C.: Rhabdomyosarcoma of the liver associated with long-term oral contraceptive use. Amer. J. Surg. Pathol. 1990; 14: 784–790
Huang, F.C., Eng, H.L., Chen, C.L., Ko, S.F.: Primary pleomorphic rhabdomyosarcoma of the liver: A case report. Hepato-Gastroenterol. 2003; 50: 73–76
Fibrosarcoma
Ito, Y., Uesaka, Y., Takeshita, S., Fujino, H., Uta, Y., Yasuda, H., Oshima, M., Kawabe, T., Tagawa, K., Unuma, T., Nakahama, M., Takanashi, R.: A case report of primary fibrosarcoma of the liver. Gastroenterol. Jpn. 1990; 25: 753–757
Nakahama, M., Takanashi, R., Yamazaki, I., Machinami, R.: Primary fibrosarcoma of the liver. Acta Pathol. Japon. 1989; 39: 814–820
Fibrous histiocytoma
Ferrozzi, F., Bova, D.: Hepatic malignant fibrous histiocytoma: CT findings. Clin. Radiol. 1998; 53: 699–701
Fujita, S., Lauwers, G.Y.: Primary hepatic malignant fibrous histiocytoma: report of a case and review of the literature. Pathol. Inst. 1998; 48: 225–229
Katsuda, S., Kawahara, E., Matsui, Y., Ohyama, S., Nakanishi, I.: Malignant fibrous histiocytoma of the liver: a case report and review of the literature. Amer. J. Gastroenterol. 1988; 83: 1278–1282
Schweyer, S., Meyer-Venter, R., Lorf, T., Sattler, B., Fayyazi, A.: Malignes fibröses Histiozytom der Leber. Z. Gastroenterol. 2000; 38: 243–248
Yu, J.S., Kim, K.W., Kim, C.S., Yoon, K.H., Jeong, H.J., Lee, D.G.: Primary malignant fibrous histiocytoma of the liver. Imaging features of five surgically confirmed cases. Abdom. Imag. 1999; 24: 386–391
Schwannoma
Morikawa, Y., Ishihara, Y., Matsuura, N., Miyamoto, H., Kakudo, K.: Malignant schwannoma of the liver. Dig. Dis. Sci. 1995; 40: 1279–1282
Young, S.J.: Primary malignant neurilemma (schwannoma) of the liver in a case of neurofibromatosis. J. Pathol. 1975; 117: 151–153
Liposarcoma
Kim, Y.I., Yu, E.S., Lee, K.W., Park, E.U., Song, H.G.: Dedifferentiated liposarcoma of the liver. Cancer 1987; 60: 2785–2790
Wright, N.B., Skinner, R., Lee, R.E., Craft, A.W.: Myxoid liposarcoma of the porta hepatis in childhood. Pediatr. Radiol. 1993; 23: 620–621
Osteosarcoma
Govender, D., Rughubar, K.N.: Primary hepatic osteosarcoma: case report and literature review. Pathology 1998; 30: 323–325
Hochstetter, A.R., Hattenschwiler, J., Vogt, M.: Primary osteosarcoma of the liver. Cancer 1987; 60: 2312–2317
Hepatic Gastrinoma
Diaz, R., Aparicio, J., Pous, S., Dolz, J.F., Calderero, V.: Primary hepatic gastrinoma. Dig. Dis. Sci. 2003; 48: 1665–1667
Moriura, S., Ikeda, S., Hirai, M., Naiki, K., Fugioka, T., Yokochi, K., Gotou, S.: Hepatic gastrinoma. Cancer 1993; 72: 1547–1550
Smyrniotis, V., Kehagias, D., Kostopanagiotou, G., Tripolitsioti, P., Paphitis, A.: Primary hepatic gastrinoma. Amer. J. Gastroenterol. 1999; 94: 3380–3382
Tiommy, E., Brill, S., Baratz, M., Messer, G., Greif, F., Moshkowitz, M., Gilat, T.: Primary liver gastrinoma. J. Clin. Gastroenterol. 1997; 24: 188–191
Van der Hoef, M., Crook, D.W., Marincek, B., Weishaupt, D.: Primary neuroendocrine tumours of the liver: MRI features in two cases. Abdom. Imag. 2004; 29: 77–81
Carcinoid tumour
Asakawa, T., Tomioka, T., Abe, K., Yamaguchi, T., Tsunoda, T., Kanematsu, T.: Primary hepatic carcinoid tumor. J. Gastroenterol. 1999; 34: 123–127
Hirata, M., Ishida, H., Konno, K., Naganuma, H., Nakajima, K., Igarashi, K., Onji, M., Iuchi, H., Nishiura, S., Maeda, T.: Primary carcinoid tumor of the liver: Report of two cases with an emphasis on US findings. Abdom. Imag. 2002; 27: 325–328
Kim, S.R., Imoto, S., Maekawa, Y., Matsuoka, T., Hayashi, Y., Ando, K., Mita, K., Shintani, S., Kim, H.B., Ku, K., Koterazawa, T., Fukuda, K., Yano, Y., Nakaji, M., Ikawa, H., Ninomiya, T., Kudo, M., Kim, K.I., Hirai, M.: CEA producing primary hepatic carcinoid. Hepatol. Res. 2002; 22: 313–321
Mizuno, Y., Ohkohchi, N., Fujimori, K., Doi, H., Orii, T., Asakura, T., Kimura, N., Pilichowska, M., Inomata, M., Satomi, S.: Primary hepatic carcinoid tumor: a case report. Hepato-Gatroenterol. 2000; 47: 528–530
Malignant lymphoma
Anthony, P.P., Sarsfield, P., Clarke, T.: Primary lymphoma of the liver: clinical and pathological features of 10 patients. J. Clin. Pathol. 1990; 43: 1007–1013
Avlonitis, V.S., Linos, D.: Primary hepatic lymphoma: a review. Eur. J. Surg. 1999; 165: 725–729
Baschinsky, D.Y., Weidner, N., Baker, P.B., Frankel, W.L.: Primary hepatic anaplastic large-cell lymphoma of T-cell phenotype in acquired immunodeficiency syndrome: a report of an autopsy case and review of the literature. Amer. J. Gastroenterol. 2001; 96: 227–232
DeMent, S.H., Mann, R.B., Staal, S.P., Kuhadja, F.P., Boitnott, J.K.: Primary lymphoma of the liver: Report of six cases and review of the literature. Amer. J. Clin. Pathol. 1987; 88: 255–263
Matsumoto, S., Mori, H., Takaki, H., Ishitobi, F., Shuto, R., Yokoyama, S.: Malignant lymphoma with tumor thrombus in the portal venous system. Abdom. Imag. 2004; 29: 460–462
Salhany, K.E., Feldman, M., Kahn, M.J., Peritt, D., Schretzmair, R.D., Wilson, D.M., DiPaola, R.S., Glick, A.D., Kant, J.A., Nowell, P.C., Kamoun, M.: Hepatosplenic γδ T-cell lymphoma: ultrastructural immunophenotypic, and functional evidence for cytotoxic T-lymphocyte differentiation. Hum. Pathol. 1997; 28: 674–685
Sato, S., Masuda, T., Oikawa, H., Satoh, T., Suzuki, Y., Takikawa, Y., Yamazaki, K., Suzuki, K., Sato, S.: Primary hepatic lymphoma associated with primary biliary cirrhosis. Amer. J. Gastroenterol. 1999; 94: 1669–1673
Zafrani, E.S., Gaulard, P.: Primary lymphoma of the liver. Liver 1993; 13: 57–61
Liver metastases
Adam, R., Bismuth, H., Castaing, D., Waechter, F., Navarro, F., Abascal, A., Majno, P., Engerran, L.: Repeat hepatectomy for colorectal liver metastases. Ann. Surg. 1997; 225: 51–62
Ambiru, S., Miyazaki, M., Isoni, T., Ito, H., Nakagawa, K., Shimizu, H., Kusashio, K., Furuya, S., Nakajima, N.: Hepatic resection for colorectal metastases — Analysis of prognostic factors. Dis. Colon Rect. 1999; 42: 632–639
Athanasakis, E., Mouloudi, E., Prinianakis, G., Kostaki, M., Tzardi, M., Georgopoulos, D.: Metastatic liver disease and fulminant hepatic failure: Presentation of a case and review of the literature. Eur. J. Gastroenterol. Hepatol. 2003; 15: 1235–1240
Bartlett, D.L., Libutti, S.K., Figg, W.D., Fraker, D.L., Alexander, H.R.: Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer. Surgery 2001; 129: 176–187
Bläker, H., Hofmann, W.J., Theuer, D., Otto, H.F.: Pathohistologic findings in liver metastases. Radiologe 2001; 41: 1–7
Botet, J.F., Watson, R.C., Kemeny, N., Daly, J.M., Yeh, S.: Cholangitis complicating intraarterial chemotherapy in liver metastases. Radiology 1985; 156: 335–337
Carlini, M., Leonardo, M.T., Carboni, F., Petric, M., Vitucci, C., Santoro, R., Lepiane, P., Ettorre, G.M., Santoro, E.: Liver metastases from 808 breast cancer. Results of surgical resection. Hepato-Gastroenterol. 2002; 49: 1597–1601
Cavallari, A., Vivarelli, M., Bellusci, R., Montalti, R., De Ruvo, N., Cuccetti, A., De Vivo, A., De Raffele, E., Salone, M.C., La Barba, G.: Liver metastases from colorectal cancer: Present surgical approach. Hepato-Gastroenterol. 2003; 50: 2067–2071
Christophi, C., Nikfarjam, M., Malcontenti-Wilson, C., Muralidharan, V.: Long-term survival of patients with unresectable colorectal liver metastases treated by percutaneous interstitial laser thermotherapy. World J. Surg. 2004; 28: 987–994
Drixler, T.A., Rinkes, I.H.M., Ritchie, E.D., van Vroonhoven, T.J.M.V., Gebbink, M.F.B.G., Voest, E.E.: Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy. Canc. Res. 2000; 60: 1761–1765
Dromain C., de Baere, T., Lumbroso, J., Caillet, H., Laplanche, A.S., Boige, V., Ducreux, M., Duvillard, P., Elias, D., Schlumberger, M., Sigal, R., Baudin, E.: Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraph, computed tomography, and magnetic resonance imaging. J. Clin Oncol. 005; 23: 70–78
Francis, A., Temple, J.G., Hallissey, M.T.: Spontaneous resolution of histologically proven liver metastases from colorectal cancer. Brit. J. Surg. 1997; 84: 818
Fretz, C.J., Stark, D.D., Metz, C.E., Elizondo, G., Weissleder, R., Shen, J.-H., Wittenberg, J., Simeone, J., Ferrucci, J.T.: Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging and iron oxide enhanced MR imaging. Amer. J. Roentgenol. 1990; 155: 763–770
Fujii, K., Fujioka, S., Kato, K., Machiki, Y., Kutsuna, Y., Ishikawa, A., Takamizawa, J., Mizutani, K., Ko, K., Youshida, K.: Factors influencing survival in 33 patients undergoing resection of hepatic metastases from colorectal cancer. Hepato-Gastroenterol. 2000; 47: 607–611
Fusai, G., Davidson, B.R.: Strategies to increase the resectability of liver metastases from colorectal cancer. Dig. Surg. 2003; 20: 481–496
Giovannini, M., Seitz, F.J.: Ultrasound-guided percutaneous alcohol injection of small liver metastases. Results in 40 patients. Cancer 1994; 73: 294–297
Haage, P., Tacke, J.: MR-guided percutaneous cryotherapy of liver metastases. Radiologe 2001; 41: 77–83
Hale, H.L., Husband, J.E., Gossios, K., Norman, A.R., Cunningham, D.: CT of calcified liver metastases in colorectal carcinoma. Clin. Radiol. 1998; 53: 735–741
Hanazaki, K., Kawamura, N., Wakabayashi, M., Sodeyama, H., Yokoyama, S., Sode, Y., Miyazaki, T.: Long-term survivor with liver metastases from rectal cancer treated by hepatectomy after hepatic arterial infusion chemotherapy. Hepato-Gastroenterol. 1998; 45: 816–820
Harrison, H.B., Middleton, H.M. III, Crosby, J.H., Dasher, M.N. jr.: Fulminant hepatic failure: an unusual presentation of metastatic liver disease. Gastroenterology 1981; 80: 820–825
Hartley, J.E., Kumar, H., Drew, P.J., Heer, K., Avery, G.R., Duthie, G.S., Monson, J.R.T.: Laparoscopic ultrasound for the detection of hepatic metastases during laparoscopic colorectal cancer surgery. Dis. Colon Rect. 2000; 43: 320–325
Heslin, M.J., Medina-Franco, H., Parker, M., Vickers, S.M., Aldrete, J., Urist, M.M.: Colorectal hepatic metastases — Resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival. Arch. Surg. 2001; 136: 318–323
Howell, J.D., Warren, H.W., Anderson, J.H., Kerr, D.J., McArdle, C.S.: Intra-arterial 5-fluorouracil and intravenous folinic acid in the treatment of liver metastases from colorectal cancer. Eur. J. Surg. 1999; 165: 652–658
Ikuta, S., Miki, C., Ookura, E., Tonouchi, H., Kusunoki, M.: Spontaneous regression of a metastatic liver tumor: Report of a case. Surg. Today 2002; 32: 844–848
Jarnagin, W.R., Conlon, K., Bodniewicz, J., Dougherty, E., DeMatteo, R.P., Blumgart, L.H., Fong, Y.: A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially respectable hepatic colorectal metastases. Cancer 2001; 91: 1121–1128
Karube, H., Masuda, H., Hayashi, S., Ishii, Y., Nemoto, N.: Fatty liver suppressed the angiogenesis in liver metastatic lesions. Hepato-Gastroenterol. 2000; 47: 1541–1545
Kerkar, S., Carlin, A.M., Sohn, R.L., Steffes, C., Tyburski, J., Littrup, P., Weaver, D.: Long-term follow up and prognostic factors for cryotherapy of malignant tumours. Surgery 2004; 136: 770–779
Kinkel, K., Lu, Y., Both, M., Warren, R.S., Thoeni, R.F.: Detection of hepatic metastases from cancer of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a metaanalysis. Radiology 2002; 224: 748–756
Koch, M., Kienle, P., Hinz, U., Antolovic, D., Schmidt, J., Hefarth, C., von Knebel doeberitz, M., Weitz, J.: Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resetion of colorectal liver metastases. Ann. Surg. 2005; 241: 199–205
Livraghi, T., Goldberg, S.N., Monti, F., Bizzini, A., Lazzaroni, S., Meloni, F., Pellicano, S., Solbiati, L., Gazelle, G.S.: Saline-enhanced radiofrequency tissue ablation in the treatment of liver metastases. Radiology 1997; 202: 205–210
Lorenz, M., Hochmuth, K., Müller, H.H.: Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer. New Engl. J. Med. 2000; 342: 1525–1526
Lygidakis, N.J., Spentzouris, N., Dedemadi, G.: Resectional liver surgery in metastatic liver disease. Hepato-Gastroenterology 1998; 45: 1034–1038
Mack, M.G., Straub, R., Eichler, K., Söllner, O., Lehnert, T., Vogl, T.J.: Breast cancer metastases in liver: Laser-induced interstitial thermotherapy. Local tumor control rate and surival data. Radiology 2004; 233: 400–409
Maeda, M., Nagawa, H., Maeda, T., Koike, H., Kasai, H.: Alcohol consumption enhances liver metastasis in colorectal carcinoma patients. Cancer 1998; 83: 1483–1488
Mala, T., Edwin, B., Mathisen, O., Tillung, T., Fosse, E., Bergan, A., Soreide, O., Gladhaug, I.: Cryoablation of colorectal liver metastases: minimally invasive tumour control. Scand. J. Gastroenterol. 2004; 39: 571–578
Middleton, W.D., Hiskes, S.K., Teefey, S.A., Boucher, L.D.: Small (1.5 cm or less) liver metastases: US-guided biopsy. Radiology 1997; 205: 729–732
Milsom, J.W., Jerby, B.L., Kessler, H., Hale, J.C., Herts, B.R., O’Malley, C.M.: Prospective blinded comparison of laparoscopic ultrasonography vs. contrast-enhanced computerized tomography for liver assessment in patients undergoing colorectal carcinoma surgery. Dis. Colon Rect. 2000; 43: 44–49
Nave, H., Mössinger, E., Feist, H., Lang, H., Raab, H.R.: Surgery as primary treatment in patients with liver metastases from carcinoid tumours: a retrospective, unicentric study over 13 years. Surgery 2001; 129: 170–175
Okano, K., Yamamoto, J., Kosuge, T., Yamamoto, S., Sakamoto, M., Nakanishi, Y., Hirohashi, S.: Fibrous pseudocapsule of metastatic liver tumors from colorectal carcinoma — clinicopathologic study of 152 first resection cases. Cancer 2000; 89: 267–275
Pereira-Lima, J.E., Lichtenfels, E., Barboso, F.S., Zettler, C.G., Uldrich-Kulczynski, J.M.: Prevalence study of metastases in cirrhotic livers. Hepato-Gastroenterol. 2003; 50: 1490–1495
Prasad, P., Schmulewitz, N., Patel, A., Varadarajulu, S., Wildi, S.M., Roberts, S., Tutuian, R., King, P., Hawes, R.H., Hoffman, B.J., Wallace, M.B.: Detection of occult liver metastases during EUS for staging of malignancies. Gastrointest. Endosc. 2004; 59: 49–53
Pulverer, G., Ko, H.L., Beuth, J., Uhlenbruck, G., Oette, K., Isenberg, J., Pichlmaier, H.: Blockage of the liver lectines due to i.v. galactose infusions: therapeutical concept regarding metastazation prophylaxis (in German). Onkologie 1995; 18(Suppl. 1): 51–54
Rivoire, M., de Cian, F., Meeus, P., Negrier, S., Sebban, H., Kaemmerlen, P.: Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases 809 from colorectal carcinoma. Long-term results. Cancer 2002; 95: 2283–2292
Rodgers, M.S., Collinson, R., Desai, S., Stubbs, R.S., McCall, J.L.: Risk of dissemination with biopsy of colorectal liver metastases. Dis. Colon Rect. 2003; 6: 454–459
Schoedel, K.E., Dekker, A.: Hemoperitoneum in the setting of metastatic cancer of the liver. A report of two cases with review of the literature. Dig. Dis. Sci. 1992; 37: 153–154
Seifert, J.K., Achenbach, T., Heintz, A., Böttger, T.C., Junginger, T.: Cryotherapy for liver metastases. Internat. J. Colorectal Dis. 2000; 15: 161–166
Shankar, A., Loizidou, M., Aliev, G., Fredericks, S., Holt, D., Boulos, P.B., Burnstock, G., Taylor, I.: Raised endothelin 1 levels in patients with colorectal liver metastases. Brit. J. Surg. 1998; 85: 502–506
Shibata, T., Murakami, T., Ogata, N.: Percutaneous microwave coagulation therapy for patients with primary and metastatic hepatic tumors during interruption of hepatic blood flow. Cancer 2000; 88: 302–311
Sica, G.T., Ji, H., Ros, P.R.: CT and MR imaging of hepatic metastases. Amer. J. Roentgenol. 2000; 174: 691–698
Soyer, P., Riopel, M., Bluemke, D.A., Scherrer, A.: Hepatic metastases from leiomyosarcoma: MR features with histopathologic correlation. Abdom. Imaging 1997; 22: 67–71
Van Riel, J.M.G.H., van Groeningen, C.J., Giaccone, G., Pinedo, H.M.: Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver. Oncology 2000; 59: 89–97
Vogl, T.J., Straub, R., Eichler, K., Söllner, O., Mack, M.G.: Colorectal carcinoma metastases in liver: Laser-induced interstitial thermotherapy. Local tumor control rate and survival data. Radiology 2004; 230: 450–458
Wein, A., Riedel, C., Bruckl, W., Merkel, S., Ott, R., Hanke, B., Baum, U., Fuchs, F., Gunther, K., Reck, T., Papadopoulos, T., Hahn, E.G., Hohenberger, W.: Neadjuvant treatment with weekly high-dose 5-fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer. Oncology 2003; 64: 131–138
Witte, R.S., Cnaan, A., Mansour, E.G., Barylak, E., Harris, J.E., Schutt, A.J.: Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma. Cancer 2001; 91: 1020–1028
Yamamoto, J., Kosuge, T., Shimada, K., Yamasaki, S., Moriya, Y., Sugihara, K.: Repeat liver resection for recurrent colorectal liver metastases. Amer. J. Surg. 1999; 178: 275–281
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
(2006). Malignant liver tumours. In: Hepatology Principles and Practice. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28977-1_37
Download citation
DOI: https://doi.org/10.1007/3-540-28977-1_37
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-28976-0
Online ISBN: 978-3-540-28977-7
eBook Packages: MedicineMedicine (R0)
